| 标题 |
[高分]
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of the American Academy of Dermatology 作者:Kristian Reich; April W. Armstrong; Peter Foley; Michael Song; Yasmine Wasfi; et al 出版日期:2017-01-05 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)